ScheBo Biotech UK Limited belongs to ScheBo Biotech AG. The rapidly growing high-tech parent company is dedicated to the development, production and worldwide distribution of innovative tests for human and veterinary diagnostics, as well as food safety.
In medical diagnostics, ScheBo Biotech is well-known for the Pancreatic Elastase 1 Stool Test ('faecal elastase'), which is rapidly becoming recognised as the "gold standard" of non-invasive pancreatic function tests. Recent guidelines produced by the British Society of Gastroenterology, and Association of Clinical Biochemist members, recommend this convenient, non-invasive, direct test of pancreatic exocrine function as "the test of first choice in patients who present with diarrhoea of putative pancreatic origin".
Highly specific monoclonal antibodies to human pancreatic elastase 1 enable quantitative determination using a single pea-sized stool sample, obviating lengthy urine or 72-hour stool collections. The development of the innovative Quick-Prep tubes has made sample preparation for the test considerably faster and more pleasant.
The ScheBo M2-PK Test is an innovative tumour marker, that measures the dimeric isoform of pyruvate kinase. The ScheBo Tumor M2-PK EDTA-Plasma Test assists monitoring the efficacy of therapy, patient follow-up and diagnosis in a wide range of different cancers, including gastrointestinal, breast, lung and urological tumours.
New and encouraging results from clinical studies with the non-invasive ScheBo Tumor M2-PK Stool Test, which is independent of occult blood, show high sensitivity combined with high specificity in colorectal cancer screening.
Further information on these tests, and on the Brainostic test in food safety and Canine Pancreatic Elastase test can be found on the company website.
What is the Role of Faecal Lactoferrin in Gastroenterological Practice?
This article discusses the role of faecal lactoferrin for the differen...article posted by ScheBo Biotech
A Decade of UK Success for ScheBo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro di...article posted by ScheBo Biotech
M2-PK Enzyme in Cancer Research
Pioneering findings in understanding cancer published in Nature: M2...article posted by ScheBo Biotech
Coeliac disease and pancreatic exocrine insufficiency
Historically, after diagnosis and the introduction of a gluten free di...article posted by ScheBo Biotech
Faecal Pancreatic Elastase Test: A Superior Alternative for Pancreolauryl Users
Change is inevitable - but is invariably for the better. October 2005...article posted by ScheBo Biotech
Faster Pancreatic Serum Test Devised by ScheBo Biotech
ScheBo Biotech, a global leader in the provision of unique diagnostic...article posted by ScheBo Biotech
Bowel Cancer Detection > Faecal M2-PK
The high sensitivity (c.80%) and high specificity (>90%) of the M2-PK...
Faecal Elastase & Lactoferrin Tests Help Gastroenterologists
Focusing on results with faecal pancreatic elastase and faecal lactofe...
- Drug Testing
- Pharmaceutical Security and Safety
- Pharmaceutical Research
- Pharmaceutical Laboratory Consumables
- Pharmaceutical & Drug Screening
- Drug Test Kits
- Diagnostics and Testing
- Medical Diagnostic Kits
- Medical Diagnostic Test
P.O. Box 6359
RG22 4WE, Basingstoke